PO.MCB03.01 · 分子与细胞生物学
RAS/MAPK Signaling, KRAS Targeting, and Adaptive Resistance
- 5976 5976 单分子水平上RAS-RAF信号的时空调控 Spatiotemporal control of RAS-RAF signaling at the single-molecule level Rodrigo E. Cáceres-Gutiérrez, Rebika Shreshta, Jean Castillo-Badillo, Vanessa Wall, Scott Eury, Katie Powell, William Burgan, Min Hong, Peter Frank, Dwight V. Nissley, Frank McCormick, Thomas Turbyville
- 5977 5977 抑制mTOR通过一个新的AKT启动的反馈环激活EGFR-MAPK网络,促进适应性耐药 mTOR inhibition activates the EGFR-MAPK network by a novel AKT-initiated feedback loop promoting adaptive resistance Keiichi Koshizuka, Hiroki Izumi, Tomohiko Ishikawa, Kuniaki Sato, Jean-Philippe Coppe, J. Silvio Gutkind
- 5978 5978 SPR2015是一种高效且选择性的KRAS G12D(ON)抑制剂,在临床前模型中作为单药对结直肠癌表现出良好的药代动力学特性和显著的抗肿瘤疗效 SPR2015, a highly potent and selective KRAS G12D (on) inhibitor, exhibits favorable pharmacokinetic behavior and significant anti-tumor efficacy against colorectal cancer as monotherapy in preclinical models Yi Qian, Zirong Zhang, Zhifei Fu, Kai Zhou, Meibi Dai, Shuqin Liu, Yang Zhang, Tao Hu
-
5979 · PDF RASurgence:ARF6促进RAS癌蛋白合成并加速肿瘤进展。 RASurgence: ARF6 boosts RAS oncoprotein synthesis and accelerates tumor progression. Gwen Kramer, Deja M. Brooks, Joshua Tay, Prachi Gupta, Sheri L. Holmen, Thomas Jacob, Allie H. Grossmann
- 5980 5980 AUBE00:一种新型环肽泛KRAS抑制剂,靶向包括KRAS突变癌症和野生型结直肠癌在内的KRAS激活型癌症 AUBE00: A novel cyclic peptide pan-KRAS inhibitor targeting KRAS-activated cancers including KRAS-mutant cancers and wild-type colorectal cancer Kana Takei, Mayuki Ueda, Toshiaki Tsunenari, Ai Shinoda, Munehiro Yuki, Hitoshi Sase, Saki Michisaka, Yukako Tachibana, Masami Hasegawa, Toshihiko Fujii, Shino Kuramoto, Miho Nagayasu, Mengxuan Gao, Kazuhiro Ohara, Keisuke Oki, Mikito Owa, Seiya Hirai, Haon Futamata, Takuya Torizawa, Hatsuo Kawada, Mirai Kage, Mikimasa Tanada, Takuya Shiraishi, Hitoshi Iikura, Takehisa Kitazawa, Hiroshi Tanaka
-
5981 · PDF 代谢应激条件决定结直肠癌中MEK1/2抑制的MAPKAPK2依赖性效力 Metabolic stress conditions dictate MAPKAPK2-dependent efficiency of MEK1/2 inhibition in colorectal carcinoma Niti Kumari, Xu Chen, Amber M. Baldwin, Kristin I. Clemons, Mohammad Alharakeh, Lilian Calisto, Balawant Kumar, Qiaoqiao Zhang, Jiang Min, Bin Xiao, Amar B. Singh, Bin Wang, Brian J. North
-
5982 · PDF 通过靶向K-RAS通路的一个主要肿瘤脆弱性——Seven in absentia homolog (SIAH)——根除转移性癌症 Eradicating metastatic cancers by targeting a major tumor vulnerability of the K-RAS pathway: Seven in absentia homolog (SIAH) Jonathan M. Baker, Emanuel Frank Petricoin, Julia Wulfkhule, Andrew Howell, Ashleigh Hannah, Amy H. Tang
-
5983 · PDF RAS加工酶Rce1的功能表征 Functional characterization of the RAS processing enzyme Rce1 David Van Dongen
-
5984 · PDF 小分子诱导的KRAS激活在表达突变型KRAS的PDAC中触发铁死亡 Small molecule induced KRAS activation triggers ferroptosis in mutant KRAS expressing PDAC Haiyuxin Zhu, Kartini Iskandar, Nur Syafiqah B. Suleiman, Benedict J. Leong, Hanqing Pang, Alessandro Carrer, Anne-Sophie ARMAND, Franck Oury, Shazib Pervaiz
-
5985 · PDF GNAS R201C在KRAS G12D驱动的胃肠道癌症模型中增强腹膜癌病 GNAS R201C enhances peritoneal carcinomatosis in K RAS G12D -driven gastrointestinal cancer models Ichiaki Ito, Saikat Chowdhury, John Paul Shen
- 5986 5986 敲除AKT1抑制PTEN缺失诱导的肝内胆管癌但不抑制小鼠肝细胞癌的发生 Deletion of AKT1 inhibits PTEN-loss induced intrahepatic cholangiocarcinoma but not hepatocellular carcinoma development in mice Ielyzaveta Slarve, Yining Ding, Yushan Wang, Zifei Xu, Lina He, Bangyan L. Stiles
-
5987 · PDF 双重靶向Pyk2/FAK和MEK/ERK通路增强对胶质母细胞瘤的生长抑制 Dual targeting of Pyk2/FAK and MEK/ERK pathways enhances growth suppression in glioblastoma Emely Morales-Colon, Kevin A. Rosa- Gonzalez, Lilia Kucheryavykh
-
5988 · PDF MEK1/2降解剂揭示MEK1/2在CRAF稳定化和成熟中不依赖激酶活性的作用 MEK1/2 degraders uncover kinase-independent role of MEK1/2 in CRAF stabilization and maturation Jason S. Wasserman, Alison M. Kurimchak, Carlos Herrera-Montávez, Glenn A. Doyle, Brandon D. Fox, Ishadi K. M. Kodikara, Jian Jin, James S. Duncan
-
5989 · PDF 在RAS-GTP驱动的肢端黑色素瘤中靶向SHOC2和GAB2 Targeting SHOC2 and GAB2 in acral melanomas driven by RAS-GTP Rony Andre Francois, Nick Lertwiriyapiti, Lucy C. Young, Matthew J. Sale, Frank McCormick
-
5990 · PDF UBE3A 和 SV2A 通过调控 MAPK 通路影响 GBM 进展 UBE3A and SV2A modulate GBM progression through MAPK pathway regulation. Lee Eunju, MIN-JEE KIM, Peter CW Lee
-
5991 · PDF p53 诱导的 FBXL20 抑制 PP2A 调节亚基 PR55alpha p53-induced FBXL20 suppresses the PP2A regulatory subunit PR55alpha Alison L. Camero, Michel Ouellette, Keith Johnson, Ying Yan
-
5992 · PDF SHP2 上的一个热点磷酸化位点驱动致癌蛋白激活和耐药 A hotspot phosphorylation site on SHP2 drives oncoprotein activation and drug resistance Prashath Karunaraj, Remkes Scheele, Malcolm L. Wells, Ipek S. Gokulu, Lila Taylor, Ruchita Rathod, Sophia Abrahamson, Lamia Chowdhury, Abiha Kazmi, Weixiao Song, Anum Glasgow, Neil Vasan
-
5993 · PDF Rho-GEF ECT2 在胰腺导管腺癌中将 Rho GTP 酶与 MEK/ERK 通路激活相连接 The Rho-GEF ECT2 links Rho GTPases to MEK/ERK pathway activation in pancreatic ductal adenocarcinoma Dania Al-Qasrawi, Nayya N. Murray, Ryan A. Argo, Alicia K. Fleming Martinez, Prita Pandya, Anaya Y. Clarke, Kayla C. Winter, Murli Krishna, Peter Storz, Nicole R. Murray, Verline Justilien
-
5994 · PDF PRL 磷酸酶过表达诱导致癌性的机制 Mechanism of oncogenicity induced by overexpression of the PRL phosphatases Jingmei Yu, Frederick Nguele Meke, Yunpeng Bai, Meaghan Maureen Broman, Haoran Zhang, Abhinanda Kar, Zhong-Yin Zhang
-
5995 · PDF 紫檀芪通过协同抑制 MAPK 和诱导凋亡增强达拉非尼在 BRAF 突变型黑色素瘤中的活性 Pterostilbene enhances dabrafenib activity in BRAF mutant melanoma through synergistic MAPK suppression and apoptotic induction Joshua Steven Fraser, Jordan Bury, Colt Summers, Jennifer Meyer, Gennie Lynne Parkman
-
5996 · PDF 评估 Pan-KRas 抑制剂 RMC-6236 对 KRas 突变型结直肠癌细胞的效应 Evaluating the effects of the Pan-KRas inhibitor RMC-6236 in KRas-mutant colorectal cancer cells Seema nadir, Sumaiya Binte Hamid, Mati Ur Rehman, Azhar Hussain Rajabali, Kulsoom K. Ghias, Arooj Shafiq
- 5997 5997 基于网络的图谱揭示了导致 KRAS G12C 肺癌 Sotorasib 耐药的机制驱动因素和可靶向枢纽 Network based mapping reveals mechanistic drivers and targetable hubs contributing to Sotorasib resistance in KRAS G12C lung cancer Atish Ranjan Mohanty, Baiyi Quan, Dana Do, Ting-Yu Wang, Tsui-Fen Chou, Prakash Kulkarni, Ravi Salgia